11/7
08:36 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
Medium
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $27.00 price target on the stock.
11/7
08:36 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
Medium
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
11/7
08:00 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
11/7
08:00 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
10/10
09:36 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "market perform" rating re-affirmed by analysts at Raymond James.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "market perform" rating re-affirmed by analysts at Raymond James.
10/10
09:36 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "market perform" rating re-affirmed by analysts at Raymond James.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "market perform" rating re-affirmed by analysts at Raymond James.
10/10
08:55 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
10/10
08:55 am
acad
Rating for ACAD
Low
Report
Rating for ACAD